ERIC VINCENT: Open Payments
NPI 1871775742 · OROVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,355 in 52 payments from 11 companies in 2025. Trend: 2023 $755 · 2024 $1,518 · 2025 $5,355
Speaker / faculty: $3,200Food & beverage: $1,895Travel & lodging: $158Education: $101
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 10 | $3,520 |
| Teva Pharmaceuticals USA, Inc. | 8 | $488 |
| Vanda Pharmaceuticals Inc. | 20 | $353 |
| Novo Nordisk Inc | 2 | $241 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $171 |
| AstraZeneca Pharmaceuticals LP | 1 | $138 |
| Amgen Inc. | 4 | $135 |
| Neurocrine BioSciences, Inc. | 1 | $128 |
| PFIZER INC. | 1 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
Products named: VOQUEZNA, FANAPT, UZEDY, CAPLYTA, AUSTEDO XR, TEZSPIRE, INGREZZA, REPATHA.
Industry payments across CA — which companies pay providers there.
